Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$15.80
+0.06%today
MKT CAP
$2.0B
+8.8% · 1Y
Earnings History
-
-
Q3 '25
Q4 '25
Analyst Targets
Current price
$15.80
Low
$35.00
Analyst Mean
$35.00
High
$35.00
2 analystsBuy
Full Financials
Trailing P/E-
Forward P/E-211.4x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+722.3%
5y Revenue CAGR+21.1%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership5.1%
Institutional Ownership3.5%
Short % of Float3.25%
Days to Cover10.4d
1 Week+3.4%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Legal & General Group PLC | institution | 0.52% | $0.01B | +4.24% | 2025-12-31 |
| Blackrock Inc. | institution | 0.52% | $0.01B | +25.16% | 2025-12-31 |
| Morgan Stanley | institution | 0.46% | $0.01B | +28.16% | 2025-12-31 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.36% | $0.01B | -10.68% | 2026-03-31 |
| Susquehanna International Group, LLP | institution | 0.33% | $0.01B | +58.33% | 2025-12-31 |
| Goldman Sachs Group Inc | institution | 0.31% | $0.01B | -2.81% | 2025-12-31 |
| Jane Street Group, LLC | institution | 0.13% | $0.00B | +311.54% | 2025-12-31 |
| Arax Advisory Partners | institution | 0.13% | $0.00B | -16.79% | 2025-12-31 |
| Citadel Advisors Llc | institution | 0.10% | $0.00B | +100.00% | 2025-12-31 |
| UBS Group AG | institution | 0.10% | $0.00B | +82.71% | 2026-03-31 |
| Penbrook Management LLC | institution | 0.07% | $0.00B | -0.57% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.02% | $0.00B | +0.00% | 2026-02-28 |
| FundVantage Trust-Polen 5Prospectives Small Growth Fund | fund | 0.01% | $0.00B | +100.00% | 2026-01-31 |
| Trust for Professional Managers-ActivePassive International Equity ETF | fund | 0.00% | $0.00B | +1.39% | 2026-02-28 |
| Invesco Exchange-Traded Fund Trust II-Invesco Nasdaq Biotechnology ETF | fund | 0.00% | $0.00B | +13.16% | 2026-03-31 |
| ProShares Trust-ProShares Ultra Nasdaq Biotechnology | fund | 0.00% | $0.00B | -9.09% | 2026-04-30 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for MESO.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.